SCHEMBL25811188

SCHEMBL25811188

Cc1ccc(-c2ccc3c(c2)sc2ccc(C)cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.37
MCL1 Q07820 2/20 0.36
BCL2L1 Q07817 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35
MAOB P27338 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
ESR2 Q92731 1/20 0.33
IDO1 P14902 1/20 0.33
LIMK1 P53667 2/20 0.33
CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10133864 0.96 BCL2L1 (0.38) ESR1MCL1BCL2L1SMN1; SMN2ALDH1A1
SCHEMBL19010386 0.91 LIMK1 (0.41) MCL1BCL2L1SMN1; SMN2ALDH1A1HPGD
SCHEMBL15599413 0.91 MCL1 (0.40) ESR1MCL1BCL2L1MAPTRAB9A
SCHEMBL15599403 0.90 MCL1 (0.42) ESR1MCL1BCL2L1SMN1; SMN2ALDH1A1
SCHEMBL13752359 0.90 SMN1; SMN2 (0.38) ESR1MCL1SMN1; SMN2ALDH1A1HPGD
SCHEMBL18267852 0.90 ESR1 (0.40) ESR1MCL1BCL2L1SMN1; SMN2ALDH1A1
SCHEMBL14680638 0.90 ESR1 (0.41) ESR1MCL1BCL2L1SMN1; SMN2ALDH1A1
SCHEMBL15315604 0.89 ALDH1A1 (0.37) MCL1BCL2L1SMN1; SMN2ALDH1A1HPGD
SCHEMBL10133866 0.89 BCL2L1 (0.41) ESR1MCL1BCL2L1SMN1; SMN2ALDH1A1
SCHEMBL25946299 0.88 PIM3 (0.43) SMN1; SMN2ALDH1A1HPGDMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-07-04 US disclosed
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM ESR1 42/4885MCL1 3777/4885BCL2L1 4557/4885
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, AOC1 ESR1 38/4885MCL1 3955/4885BCL2L1 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.